메뉴 건너뛰기




Volumn 5, Issue 4, 2004, Pages 472-476

Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity

Author keywords

A; Breast cancer; Interleukin 18; R737.9; Transfection; Tumorigenesis

Indexed keywords

CANCER CELLS; CELL CULTURE; DISEASES; GENE EXPRESSION; LIPOSOMES; MAMMALS; VACCINES;

EID: 6044224746     PISSN: 1673565X     EISSN: 18621775     Source Type: Journal    
DOI: 10.1631/jzus.2004.0472     Document Type: Article
Times cited : (12)

References (14)
  • 1
    • 0032169511 scopus 로고    scopus 로고
    • IL-18 augmens perforin-dependent cytotoxicity of liver NK-T cells
    • Dao, T., Mehal, W.Z., Crispe, I.N., 1998. IL-18 augmens perforin-dependent cytotoxicity of liver NK-T cells.J. Immunol.,61:2217–2222. DOI: 10.4049/jimmunol.161.5.2217
    • (1998) J. Immunol. , vol.61 , pp. 2217-2222
    • Dao, T.1    Mehal, W.Z.2    Crispe, I.N.3
  • 2
    • 0033565876 scopus 로고    scopus 로고
    • Differential antitumor effects of administration of rIL-18 or RIL-12 are mediated primarily by Fas-Fas Ligand- and perforin-induced tumor apoptosis, respectively
    • Hashimoto, W., Oksaki, T., Okamura, H., Robbins, P.D., Kurimoto, M., Nagata, S., Lotze, M.T., Tahara, H., 1999. Differential antitumor effects of administration of rIL-18 or RIL-12 are mediated primarily by Fas-Fas Ligand- and perforin-induced tumor apoptosis, respectively.J. Immunol,163:583–589. DOI: 10.4049/jimmunol.163.2.583
    • (1999) J. Immunol , vol.163 , pp. 583-589
    • Hashimoto, W.1    Oksaki, T.2    Okamura, H.3    Robbins, P.D.4    Kurimoto, M.5    Nagata, S.6    Lotze, M.T.7    Tahara, H.8
  • 3
    • 0030766468 scopus 로고    scopus 로고
    • Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma
    • Micallef, M.J., Tanimoto, T., Kohno, K., Ikeda, M., Kurimoto, M., 1997a. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.Cancer Res.,57:4557–4563.
    • (1997) Cancer Res. , vol.57 , pp. 4557-4563
    • Micallef, M.J.1    Tanimoto, T.2    Kohno, K.3    Ikeda, M.4    Kurimoto, M.5
  • 5
    • 0033559876 scopus 로고    scopus 로고
    • Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12
    • Okamoto, I., Kohno, K., Tanimoto, T., Ikegami, H., Kurimoto, M., 1999. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.J. Immunol,162:3202–3211. DOI: 10.4049/jimmunol.162.6.3202
    • (1999) J. Immunol , vol.162 , pp. 3202-3211
    • Okamoto, I.1    Kohno, K.2    Tanimoto, T.3    Ikegami, H.4    Kurimoto, M.5
  • 6
  • 8
    • 2642674449 scopus 로고    scopus 로고
    • IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects
    • Osaki, T., Peron, J.M., Cai, Q., Okamura, H., Robbins, P.D., Kurimoto, M., Letze, M.T., Tahara, H., 1998. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects.J. Immunol,160:1742–1749. DOI: 10.4049/jimmunol.160.4.1742
    • (1998) J. Immunol , vol.160 , pp. 1742-1749
    • Osaki, T.1    Peron, J.M.2    Cai, Q.3    Okamura, H.4    Robbins, P.D.5    Kurimoto, M.6    Letze, M.T.7    Tahara, H.8
  • 9
    • 0033019078 scopus 로고    scopus 로고
    • Potent antitumor effects mediated by local expression of the mature form of the IFN-γ-inducing factor, interleukin-18 (IL-18)
    • Osaki, T., Hashimoto, W., Gambotto, A., Okamura, H., Robbins, P.D., Kurimoto, M., Lotze, M.T., Tahara, H., 1999. Potent antitumor effects mediated by local expression of the mature form of the IFN-γ-inducing factor, interleukin-18 (IL-18).Gene Ther,6:808–815. DOI: 10.1038/sj.gt.3300908
    • (1999) Gene Ther , vol.6 , pp. 808-815
    • Osaki, T.1    Hashimoto, W.2    Gambotto, A.3    Okamura, H.4    Robbins, P.D.5    Kurimoto, M.6    Lotze, M.T.7    Tahara, H.8
  • 10
    • 85170084642 scopus 로고    scopus 로고
    • Modulation of interleukin-18 expression expression in human colon carcinoma: consequence for tumor immune surveillance
    • Pages, F., Berger, A., Henglein, B., Piqueras, B., Danel, C., Zinzindahooouse, F., Thiounn, N., Cagnenc, P.H., Fridman, W.H., 1999. Modulation of interleukin-18 expression expression in human colon carcinoma: consequence for tumor immune surveillance.Int J Cancer,84(3):13962–13966. DOI: 10.1002/(SICI)1097-0215(19990621)84:3<326::AID-IJC22>3.0.CO;2-K
    • (1999) Int J Cancer , vol.84 , Issue.3 , pp. 13962-13966
    • Pages, F.1    Berger, A.2    Henglein, B.3    Piqueras, B.4    Danel, C.5    Zinzindahooouse, F.6    Thiounn, N.7    Cagnenc, P.H.8    Fridman, W.H.9
  • 11
    • 0030694235 scopus 로고    scopus 로고
    • IGIF does not drive Th1 development but sunergizes with IL-12 for interferongamma productionand activates IRAK and NF kappaB
    • Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S.B., Menon, S., Kastelein, R., Bazan, F., O'Garra, A., 1997. IGIF does not drive Th1 development but sunergizes with IL-12 for interferongamma productionand activates IRAK and NF kappaB.Immunity,7(4):571–581. DOI: 10.1016/S1074-7613(00)80378-7
    • (1997) Immunity , vol.7 , Issue.4 , pp. 571-581
    • Robinson, D.1    Shibuya, K.2    Mui, A.3    Zonin, F.4    Murphy, E.5    Sana, T.6    Hartley, S.B.7    Menon, S.8    Kastelein, R.9    Bazan, F.10    O'Garra, A.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.